Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NeuroPace ( (NPCE) ) just unveiled an update.
NeuroPace is set to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, showcasing their latest advancements in neurological medical devices. The presentation will be accessible via a live audio webcast, potentially enhancing the company’s visibility and stakeholder engagement.
More about NeuroPace
NeuroPace, Inc. operates in the healthcare industry, primarily focusing on medical devices designed for neurological applications.
YTD Price Performance: 2.25%
Average Trading Volume: 88,595
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $353.4M
For an in-depth examination of NPCE stock, go to TipRanks’ Stock Analysis page.